| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/05/2002 | CA2078578C Medical use for tachykinin antagonists |
| 02/05/2002 | CA2051418C Novel vitamin d analogues |
| 02/05/2002 | CA2051288C Viral targeted destruction of neoplastic cells |
| 02/05/2002 | CA2050623C Ointments containing tricyclic compound |
| 02/05/2002 | CA2045290C Plaster with a high content of softening ingredients |
| 02/05/2002 | CA2019749C [.alpha.-(tert.butyl aminomethyl)-3,4-dichlorobenzyl] thioacetamide, a procedure for its preparation and its uses |
| 02/04/2002 | CA2354253A1 Polypeptides or nucleic acids encoding these of a family of g-protein coupled receptors and their use for the diagnosis or treatment of disorders, for example skin disorders and their use for the identification of pharmacologically active substances |
| 02/03/2002 | CA2353364A1 Aerosol for the treatment or prevention of pain |
| 02/01/2002 | WO2001007617A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2380942A1 Human homologue of bovine neuroendocrine secretory protein, nesp55, polynucleotides and uses thereof linked with obesity |
| 02/01/2002 | CA2354342A1 Alkyl amino acid derivatives useful as pharmaceutical agents |
| 01/31/2002 | WO2002008475A2 Method for recovery of copper from sulfidic ore materials using super-fine grinding and medium temperature pressure leaching |
| 01/31/2002 | WO2002008446A2 Synthesis and antiviral evaluation of nucleic acid based (nab) libraries |
| 01/31/2002 | WO2002008434A2 Bicistronic influenza comprising two genes in tandem |
| 01/31/2002 | WO2002008420A2 A method of down-regulating gene expression |
| 01/31/2002 | WO2002008401A2 Elongase genes and uses thereof |
| 01/31/2002 | WO2002008295A1 Heparin-derived polysaccharide mixtures, preparation method and pharmaceutical compositions containing same |
| 01/31/2002 | WO2002008292A2 Human monoclonal antibody against hepatitis c virus e2 glycoprotein |
| 01/31/2002 | WO2002008286A2 Zinc finger domain recognition code and uses thereof |
| 01/31/2002 | WO2002008271A1 Novel fibroblast growth factor (fgf23) and methods for use |
| 01/31/2002 | WO2002008267A2 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 01/31/2002 | WO2002008256A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008255A2 Cell cycle proteins and mitosis-associated molecules |
| 01/31/2002 | WO2002008244A2 Peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008242A1 Nucleic acids comprising regions of the rat peg-3 promoter and uses thereof |
| 01/31/2002 | WO2002008241A2 Prodrugs of phosphonate nucleotide analogues and methods for selecting and making same |
| 01/31/2002 | WO2002008235A1 Medicament for oral application, containing aminopropyl phosphonic acid esters as an active ingredient |
| 01/31/2002 | WO2002008232A1 4-phenyl-pyridine derivatives as neurokinin-1 receptor antagonists |
| 01/31/2002 | WO2002008231A2 Biologically active macrolides, compositions, and uses thereof |
| 01/31/2002 | WO2002008226A2 Tricyclic 2-pyridone compounds useful as hiv reverse transcriptase inhibitors |
| 01/31/2002 | WO2002008225A1 2-(1h-indol-3-yl)-2-oxo-acetic acid amides with antitumor activity |
| 01/31/2002 | WO2002008224A1 Aminopiperidine quinolines and their azaisosteric analogues with antibacterial activity |
| 01/31/2002 | WO2002008223A1 Indole derivatives useful for the treatment of cns disorders |
| 01/31/2002 | WO2002008221A2 Capsaicin receptor ligands |
| 01/31/2002 | WO2002008219A2 2-adamantylethylamines and their use in the treatment of conditions generally associated with abnormalities in glutamatergic transmission |
| 01/31/2002 | WO2002008218A1 Cyclic substituted aminomethyl compounds and medicaments containing said compounds |
| 01/31/2002 | WO2002008217A2 COUMARIN DERIVATIVES USEFUL AS TNFα INHIBITORS |
| 01/31/2002 | WO2002008216A1 Novel compounds and their use as glycine transport inhibitors |
| 01/31/2002 | WO2002008213A1 Colchinol derivatives as angiogenesis inhibitors |
| 01/31/2002 | WO2002008212A1 Novel form of (r)-n-[5-methyl-8-(4-methylpiperazin-1-yl)-1,2,3,4-tetrahydro-2-naphthyl]-4-morpholinobenzamide |
| 01/31/2002 | WO2002008210A1 Cyanomethyl substituted thiazoliums and imidazoliums and treatments of disorders associated with protein aging |
| 01/31/2002 | WO2002008209A1 Alpha-acyl and alpha-heteroatom-substituted benzene acetamide glucokinase activators |
| 01/31/2002 | WO2002008208A1 Process for the preparation of optically active thiazolidinone derivatives |
| 01/31/2002 | WO2002008205A1 Substituted 5-alkynyl pyrimidines having neurotrophic activity |
| 01/31/2002 | WO2002008204A2 5-substituted pyrimidine derivatives of conformationally locked nucleoside analogues |
| 01/31/2002 | WO2002008200A2 Arylethene-sulfonamides, their preparation and their use as endothelin antagonists |
| 01/31/2002 | WO2002008198A2 Novel imidazolidinones as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008197A1 Biphenyl carboxamides |
| 01/31/2002 | WO2002008195A1 Pyrazolyl biphenyl carboxamides and the use thereof for controlling undesired microorganisms |
| 01/31/2002 | WO2002008194A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
| 01/31/2002 | WO2002008193A2 Therapeutic acridone and acridine compounds |
| 01/31/2002 | WO2002008192A1 Novel heteroaryl derivatives and the use thereof as pharmaceuticals |
| 01/31/2002 | WO2002008190A2 Novel heteroaryl derivatives and use thereof as anti-tumour agents |
| 01/31/2002 | WO2002008189A1 Compounds and inhibitors of phospholipases |
| 01/31/2002 | WO2002008188A1 N-substituted indoles useful in the treatment of diabetes |
| 01/31/2002 | WO2002008187A1 Novel peptides as ns3-serine protease inhibitors of hepatitis c virus |
| 01/31/2002 | WO2002008186A2 Cyclopentanoindoles, compositions containing such compounds and methods of treatment |
| 01/31/2002 | WO2002008185A1 Pyrrolidine derivatives as metalloprotease inhibitors |
| 01/31/2002 | WO2002008182A1 Method for the production of a water-dispersible formulation containing carotenoids |
| 01/31/2002 | WO2002008179A1 Aryl sulfonamides as serotonin antagonist for the treatment of obesity |
| 01/31/2002 | WO2002008178A1 New combination of serotonin agonist (5ht2) and antagonist (5ht6)as pharmaceutical formulation |
| 01/31/2002 | WO2002008174A1 Phenylethylamine derivatives and their use in the treatment of melanoma |
| 01/31/2002 | WO2002008172A1 Process for the preparation of substituted octanoyl amides |
| 01/31/2002 | WO2002007823A2 Inhibition of mutagenic effects of carcinogens |
| 01/31/2002 | WO2002007822A2 Carbamate compounds for use in preventing or treating neuropathic pain and cluster and migraine headache-associated pain |
| 01/31/2002 | WO2002007782A2 Diagnosis of liver disease |
| 01/31/2002 | WO2002007772A2 Improved oral dosage formulations |
| 01/31/2002 | WO2002007771A1 Pharmaceutically active compound |
| 01/31/2002 | WO2002007770A2 Polymeric conjugates of antitumor agents |
| 01/31/2002 | WO2002007767A2 Pharmaceutical suspension compositions lacking a polymeric suspending agent |
| 01/31/2002 | WO2002007766A2 Use of d5-dopamine receptor agonists in the manufacture of a medicament for the treatment of dyskinesia |
| 01/31/2002 | WO2002007765A2 REGULATORS OF PPARδ(β) AND THEIR USE IN THE TREATMENT OF OBESITY AND INSULIN RESISTANCE |
| 01/31/2002 | WO2002007747A1 Methods of modulating fibrosis |
| 01/31/2002 | WO2002007744A1 Essential oil combination and therapeutic uses thereof |
| 01/31/2002 | WO2002007738A1 Combinations of chitosan and psyllium for synergistic adsorption of triglyceride and cholesterol |
| 01/31/2002 | WO2002007737A1 Method for the treatment of glaucoma and ocular hypertension by administering nucleotides |
| 01/31/2002 | WO2002007734A1 Compositions and methods of preventing or reducing the risk or incidence of skeletal injuries in horses |
| 01/31/2002 | WO2002007733A2 Method for enhancing bone mineral density gain by administration of raloxifene |
| 01/31/2002 | WO2002007732A2 Use of panaxatriol for stimulation angiogenesis |
| 01/31/2002 | WO2002007731A2 Composition containing a 15-keto prostaglandin compound for treating of ocular hypertension and glaucoma |
| 01/31/2002 | WO2002007730A1 Alpha v integrin receptor antagonists |
| 01/31/2002 | WO2002007729A1 Non-sedating barbiturate compounds as neuroprotective agents |
| 01/31/2002 | WO2002007728A1 Hair loss prevention |
| 01/31/2002 | WO2002007727A1 Use of pyridazino(4,5-)indole-1-acetamide derivatives for preparing medicines for treating pathologies related to the dysfunction of peripheral benzodiazepin receptors |
| 01/31/2002 | WO2002007726A2 Treatment of movement disorders |
| 01/31/2002 | WO2002007725A1 Method for treating fibrotic diseases or other indications ic |
| 01/31/2002 | WO2002007724A1 FREEZE-DRIED PREPARATION OF N-[o-(p-PIVALOYLOXYBENZENESULFONYLAMINO)BENZOYL]GLYCINE MONOSODIUM SALT TETRAHYDRATE AND PROCESS FOR PRODUCING THE SAME |
| 01/31/2002 | WO2002007723A1 Compositions for regulating desire for smoking |
| 01/31/2002 | WO2002007722A2 Valproic acid and derivatives thereof as histone deacetylase inhibitors |
| 01/31/2002 | WO2002007721A2 Use of cox-2 inhibitors for preventing immunodeficiency |
| 01/31/2002 | WO2002007720A1 Compounds having mif antagonist activity |
| 01/31/2002 | WO2002007719A1 Use of estramustine phosphate in the treatment of bone metastasis |
| 01/31/2002 | WO2002007718A1 Method for the treatment of climacteric disorders in women during or after the menopause |
| 01/31/2002 | WO2002007717A1 Emulsion of perfluororganic compounds for medical purposes, method for producing said emulsion and methods for curing and preventing diseases with the aid of the emulsion |
| 01/31/2002 | WO2002007716A2 Method for treating angina |
| 01/31/2002 | WO2002007715A2 A method for treating celiac disease |
| 01/31/2002 | WO2002007714A2 Use of anellated dihydropyridines for the preparation of pharmaceutical compositions for the treatment of chronic pain |
| 01/31/2002 | WO2002007712A2 Self-emulsifying drug delivery systems for extremely water-insoluble, lipophilic drugs |
| 01/31/2002 | WO2002007708A1 Lyophilized powder of lentinan and the process of preparation thereof |
| 01/31/2002 | WO2002007706A1 Method for coating solid particles with a thermofusible agent, and resulting coated solid particles |